Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin vs Atorvastatin in Metabolic Syndrome (KREST)
NCT00335699Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in hypercholesterolemia, metabolic syndrome, sponsored by AstraZeneca. Started Aug 2005; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiametabolic syndrome
Beyond the preview
Go deeper on NCT00335699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335699.